Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective study

被引：0
|
作者：
Bertani, L. [1 ,2 ]
D'Alessandro, C. [1 ]
Fornili, M. [3 ]
Coppini, F. [1 ]
Zanzi, F. [1 ]
Carmisciano, L. [3 ]
Geri, F. [1 ]
Svizzero, G. Baiano [4 ]
Ceccarelli, L. [4 ]
机构：
[1] Univ Pisa, Translat Res & New Technol Med & Surg, Pisa, Italy
[2] Tuscany North West ASL Pontedera Hosp, Gen Surg & Gastroenterol, Pontedera, Italy
[3] Univ Pisa, Clin & Expt Med, Pisa, Italy
[4] Pisa Univ Hosp, Gen Surg & Gastroenterol, Pisa, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P678
引用
收藏
页码：810 / 810
页数：1
相关论文
共 50 条
  • [1] ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN'S DISEASE
    Bertani, L.
    D'Alessandro, C.
    Fornili, M.
    Coppini, F.
    Zanzi, F.
    Geri, F.
    Mumolo, M. G.
    Bellini, M.
    Baglietto, L.
    De Bortoli, N.
    Costa, F.
    DIGESTIVE AND LIVER DISEASE, 2022, 54 : S138 - S139
  • [2] Response to Ustekinumab Therapy Is Associated with an Improvement of Nutritional Status in Patients with Crohn's Disease
    Bertani, Lorenzo
    DAlessandro, Claudia
    Fornili, Marco
    Coppini, Francesca
    Zanzi, Federico
    Carmisciano, Luca
    Geri, Francesca
    Svizzero, Giovanni Baiano
    Rosi, Emma Maria
    De Bernardi, Alice
    Ceccarelli, Linda
    Mumolo, Maria Gloria
    Baglietto, Laura
    Bellini, Massimo
    De Bortoli, Nicola
    Costa, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [3] Intestinal permeability and nutritional status in Crohn's disease.
    Zoli, G
    Care, M
    Falco, F
    Parazza, M
    Spano, C
    Montalto, M
    Mingrone, G
    Bernardi, M
    Gasbarrini, G
    GASTROENTEROLOGY, 1996, 110 (04) : A1055 - A1055
  • [4] Ustekinumab therapy for Crohn's disease
    Iain Dickson
    Nature Reviews Gastroenterology & Hepatology, 2017, 14 (1) : 4 - 4
  • [5] Efficacy of Ustekinumab Therapy in Patients With Perianal Crohn's Disease
    Manski, Scott
    Dioguardi, Vincent
    Weil, Blake J.
    Edirisuriya, Chelsea
    Gandhi, Hema K.
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S847 - S847
  • [6] Crohn's Disease: Maintenance Therapy with Ustekinumab
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (12): : 1276 - +
  • [7] Letter: optimising response to ustekinumab therapy for patients with Crohn's disease
    Hudson, Joshua
    Herfarth, Hans H.
    Barnes, Edward L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (05) : 906 - 906
  • [8] Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn's disease. A real life study
    Gomez Espin, Rosa
    Nicolas de Prado, Isabel
    Gil Candel, Mayte
    Gonzalez Carrion, Marta
    Rentero Redondo, Lorena
    Iniesta Navalon, Carles
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (02) : 110 - 115
  • [9] Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
    Feagan, B. G.
    Sandborn, W. J.
    Gasink, C.
    Jacobstein, D.
    Lang, Y.
    Friedman, J. R.
    Blank, M. A.
    Johanns, J.
    Gao, L. -L.
    Miao, Y.
    Adedokun, O. J.
    Sands, B. E.
    Hanauer, S. B.
    Vermeire, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W. J.
    Colombel, J. -F.
    Tulassay, Z.
    Seidler, U.
    Salzberg, B. A.
    Desreumaux, P.
    Lee, S. D.
    Loftus, E. V., Jr.
    Dieleman, L. A.
    Katz, S.
    Rutgeerts, P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (20): : 1946 - 1960
  • [10] Crohn's Disease: Induction and Maintenance Therapy with Ustekinumab
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (01): : 14 - +
12345